EU FLAG

EU H2020 – ERANET III Cofunding Scheme

Nanotechnology based immunotherapy for glioblastoma - NANOGLIO

Time: 3 years; Budget: 900 K€

NANOGLIO GOALS:

  • to develop nanotechnology based systems for targeted delivery of immunomodulative agents in the view of elaborating and validating innovative immunotherapeutic approaches against GBM.

Pricl et al., Self-assembling supramolecular dendrimer nanosystem for PET imaging of tumors. Proceeding of the National Academy of Science USA 2018;15:11454-11459; A dual targeting dendrimer-mediated siRNA delivery system for effective gene silencing in cancer therapy. Journal of the American Chemical Society 2018;140:16264-16274.

Pricl et al., Self-assembling supramolecular dendrimer nanosystem for PET imaging of tumors. Proceeding of the National Academy of Science USA 2018;15:11454-11459; A dual targeting dendrimer-mediated siRNA delivery system for effective gene silencing in cancer therapy. Journal of the American Chemical Society 2018;140:16264-16274.

Pricl et al., Self-assembling supramolecular dendrimer nanosystem for PET imaging of tumors. Proceeding of the National Academy of Science USA 2018;15:11454-11459; A dual targeting dendrimer-mediated siRNA delivery system for effective gene silencing in cancer therapy. Journal of the American Chemical Society 2018;140:16264-16274.Pricl et al., Self-assembling supramolecular dendrimer nanosystem for PET imaging of tumors. Proceeding of the National Academy of Science USA 2018;15:11454-11459; A dual targeting dendrimer-mediated siRNA delivery system for effective gene silencing in cancer therapy. Journal of the American Chemical Society 2018;140:16264-16274.